研究業績
ホーム > 研究業績
| 国際学会発表（2025） | |
|---|---|
| 発表者・ 共演者 |
Yoshino H, Enokida H: |
| 題名 | Boosting survival in advanced urothelial carcinoma:The power of CBM588 probiotic and pembrolizumab combination. |
| 学会名 | 2025 ASCO Genitourinary Cancers Symposium, 2025.2.14. |
| 開催地 | San Francisco, USA |
| 発表者・ 共演者 |
Yoshino H: |
| 題名 | Comparative Analysis of MUC1 Promoter Methylation Patterns Using Next-Generation Sequencing: Potential for Early Detection of Clear Cell Renal Cell Carcinoma. |
| 学会名 | 40th Annual EAU Congress (EAU25), 2025.3.21. |
| 開催地 | Madrid, Spain, |
| 発表者・ 共演者 |
Yoshino H, Enokida H: |
| 題名 | MEK1 as a Synthetic Lethal Target with Cabozantinib in Renal Cell Carcinoma: Insights from CRISPR/Cas9 Screening. |
| 学会名 | American Urological Association (AUA) 2025, 2025.4.28. |
| 開催地 | Las Vegas, USA, |
| 発表者・ 共演者 |
Arima J, Yoshino H, Fukuda I, Li Gang, Tominaga M, Saito S, Sakaguchi T, Tatarano S, Enokida H: |
| 題名 | Serum exosomal IncRNA BCYRN1: A novel biomarker for renal cell carcinoma. |
| 学会名 | American Urological Association (AUA)2025, 2025.4.28. |
| 開催地 | Las Vegas, USA, |
| 発表者・ 共演者 |
Arima J, Yoshino H, Li Gang, Tominaga M, Saito S, Sakaguchi T, Tatarano S, Enokida H: |
| 題名 | Prognostic of Clostridium butyricum MIYAIRI(CBM588)in combination with pembrolizumab for advanced urothelial carcinoma. |
| 学会名 | American Urological Association (AUA)2025, 2025.4.29. |
| 開催地 | Las Vegas, USA, |
| 英文論文業績（2025） | |
|---|---|
| 発表者・ 共演者 |
Sakaguchi T, Osako Y, Mitsuke A, Ogawa R, Takeyama H, Matsushita R, Yoshino H, Tatarano S, Enokida H: |
| 題名 | Giant calyceal diverticulum diagnosed in pregnancy: A case report of successful percutaneous catheter management during pregnancy and robot-assisted calyceal diverticulectomy after delivery. |
| 雑誌名 | Urology Case Reports.59:102935,2025. |
| 発表者・ 共演者 |
Saito S, Yoshino H, Yokoyama S, Tominaga M, Li G, Arima J, Kawahara I, Fukuda I, Mitsuke A, Sakaguchi T, Inoguchi S, Matsushita R, Yamada Y, Tatarano S, Tanimoto A, Enokida H: |
| 題名 | Targeting Heat Shock Transcription Factor 4 Enhances the Efficacy of Cabozantinib and Immune Checkpoint Inhibitors in Renal Cell Carcinoma. |
| 雑誌名 | Int J Mol Sci, 26:1776,2025. |
| 国際学会発表（2024） | |
|---|---|
| 発表者・ 共演者 |
Fukumoto W, Yoshino H, Saito S, Li G, Arima J, Kawahara I, Sakaguchi T,Tatarano S, Enokida H. |
| 題名 | A novel therapeutic target SCG2 might cooperate with HIF1α in TKI-resistant renal cell carcinoma. |
| 学会名 | AUA2024, May 3-6. |
| 開催地 | San Antonio, USA. |
| 発表者・ 共演者 |
Saito S, Yoshino H, Tominaga M, Li G, Arima J, Sakaguchi T, Tatarano S, Enokida H: |
| 題名 | Therapeutic strategies for renal cell carcinoma targeting HSF4. |
| 学会名 | The 3rd Annual Metting of KUOS-EAUOS, 2024.9.28. |
| 開催地 | Seoul, Korea. |
| 発表者・ 共演者 |
Yoshino H, Arima J, Saito S, Enokida H: |
| 題名 | LncRNA BCYRN1 in Serum Exosomes: A Potential therapeutic Target and Diagnostic Maker for Bladder Cancer. |
| 学会名 | The 3rd Annual Metting of KUOS-EAUOS, 2024.9.28. |
| 開催地 | Seoul, Korea. |
| 発表者・ 共演者 |
Saito S, Yoshino H, Tominaga M, Li G, Arima J, Sakaguchi T, Tatarano S, Enokida H: |
| 題名 | Therapeutic strategies for renal cell carcinoma targeting HSF4. |
| 学会名 | The 40th Korea-Japan Urological Congress (KJUC), 2024.11.9. |
| 開催地 | Gwangju, Korea. |
| 発表者・ 共演者 |
Hirofumi Y: |
| 題名 | Cancer immunotherapy with probiotics for urothelial carcinoma in kagoshima university. |
| 学会名 | The 40th Korea-Japan Urological Congress (KJUC),2024.11.9. |
| 開催地 | Gwangju, Korea. |
| 英文論文業績（2024） | |
|---|---|
| 発表者・ 共演者 |
Sakaguchi T, Mitsuke A, Osako Y, Yamada Y, Takeyama H, Ogawa R, Takahashi K, Hirohata Y, Yamamoto S, Arima J, Fukumoto W, Sugita S, Inoguchi S, Matsushita R, Yoshino H, Tatarano S, Enokida H. |
| 題名 | Assessing antiviral treatment efficacy and risk factors for severe COVID-19 in kidney transplant recipients during the Omicron subvariant-dominant period: a retrospective study. |
| 雑誌名 | BMC Nephrology. Volume 25, article number 124, (2024) |
| 発表者・ 共演者 |
Kofuji S, Wolfe K, Sumita K, Kageyama S, Yoshino H, Hirota Y, Ogawa-Iio A, Kanoh H, Sasaki M, Kofuji K, Davis MI, Pragani R, Shen M, Boxer MB, Nakatsu F, Nigorikawa K, Sasaki T, Takeuchi K, Senda T, Kim SM, Edinger AL, Simeonov A, Sasaki AT. |
| 題名 | A high dose KRP203 induces cytoplasmic vacuoles associated with altered phosphoinositide segregation and endosome expansion. |
| 雑誌名 | BBRC. Available online 27 April 2024, 149981 |
| 発表者・ 共演者 |
Kawahara I, Yoshino H, Fukumoto W, Arima J, Saito S, Li G, Fukuda I, Mitsuke A, Sakaguchi T, Inoguchi S, Matsushita R, Nakagawa M, Tatarano S, Yamada Y, Enokida H: |
| 題名 | Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine-and cisplatin-resistant models. |
| 雑誌名 | Molecular Oncology. 18:2196-2211,2024. |
| 発表者・ 共演者 |
Arima J, Yoshino H, Fukumoto W, Kawahara I, Saito S, Li G, Fukuda I, Iizasa S, Mitsuke A, Sakaguchi T, Inoguchi S, Matsushita R, Nakagawa M, Tatarano S, Yamada Y, Enokida H: |
| 題名 | LncRNA BCYRN1 as a Potential Therapeutic Target and Diagnostic Marker in Serum Exosomes in Bladder Cancer. |
| 雑誌名 | Int J Mol Sci.25:5955, 2024. |
| 発表者・ 共演者 |
Fukumoto W, Okamura S, Tamai M, Arima J, Kawahara I, Fukuda I, Mitsuke A, Sakaguchi T, Sugita S, Matsushita R, Tatarano S, Yamada Y, Nakagawa M, Enokida H, Yoshino H: |
| 題名 | Development of a novel treatment based on PKMYT1 inhibition for cisplatin-resistant bladder cancer with miR-424-5p-dependent cyclin E1 amplification. |
| 雑誌名 | BMC Cancer. 24:1333,2024. |
| 国際学会発表（2023） | |
|---|---|
| 発表者・ 共演者 |
Ho Kyung S, Enokida H, Haolun L. (Chair) |
| 題名 | Moderated Poster. |
| 学会名 | 2023 The 2nd Annual Metting of KUOS-EAUOS |
| 開催地 | INCHEON, KOREA |
| 発表者・ 共演者 |
Kawahara I, Yoshino H, Fukumoto W, Arima J, Saito S, Sakaguchi T, Tatarano S, Enokida H. |
| 題名 | Novel Findings of Cancer-related Metabolisms in Gemcitabine/Cisplatin-resistant Bladder Cancer Cells. |
| 学会名 | 2023 The 2nd Annual Metting of KUOS-EAUOS |
| 開催地 | INCHEON, KOREA |
| 発表者・ 共演者 |
Arima J, Yoshino H, Saito S, Li G, Kawahara I, Sakaguchi T, Tatarano S, Enokida H. |
| 題名 | Serum Exosomal BCYRN1: A Potential lncRNA for Therapeutic and Diagnostic Target in Bladder Cancer. |
| 学会名 | 2023 The 2nd Annual Metting of KUOS-EAUOS |
| 開催地 | INCHEON, KOREA |
| 発表者・ 共演者 |
Yoshino H, Tatarano S, Enokida H. |
| 題名 | Exosomal IncRNA BCYRN1 can be a target for diagnosis and therapy in renal cell carcinoma. |
| 学会名 | AUA2023. April28-May1. |
| 開催地 | CHICAGO, USA |
| 発表者・ 共演者 |
Arima J, Yoshino H, Kawahara I, Fukumoto W, Kawakami I, Tamai M, Tatarano S, Enokida H. |
| 題名 | SMARCD1 regulated by microRNA-99a-5p contributes to gemcitabine resistance in bladder cancer via suppression of cellular senescence. |
| 学会名 | AUA2023. April28-May1. |
| 開催地 | CHICAGO, USA |
| 発表者・ 共演者 |
Yoshino H, Arima J, Fukumoto W, Kawahara I, Tatarano S, Enokida H. |
| 題名 | Exosomal IncRNA BCYRN1 as a target for diagnosis and therapy in renal cell carcinoma. |
| 学会名 | EAU23. March10-13. |
| 開催地 | MILAN, ITALY |
| 発表者・ 共演者 |
Fukumoto W, Yoshino H, Arima J, Kawahara I, Kawakami I, Tamai M, Tatarano S, Enokida H. |
| 題名 | SCG2 might be a new molecule in sunitinib-resistant renal cells. |
| 学会名 | EAU23. March10-13. |
| 開催地 | MILAN, ITALY |
| 英文論文業績（2023） | |
|---|---|
| 発表者・ 共演者 |
Mitsuke A, Ohbo T, Arima J, Osako Y, Sakaguchi T, Matsushita R, Yoshino H, Tatarano S, Yamada Y, Sasaki H, Tanabe T, Fukuzawa N, Tanaka H, Nishio Y, Enokida H, Harada H. |
| 題名 | Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients. |
| 雑誌名 | PLoS One .18:e0287059.2023. |
| 発表者・ 共演者 |
Yoshino H, Yokoyama S, Tamai M, Okamura S, Iizasa S, Sakaguchi T, Osako Y, Inoguchi S, Matsushita R, Yamada Y, Nakagawa M, Tatarano S, Tanimoto A, Enokida H. |
| 題名 | Characterization and treatment of gemcitabine- and cisplatin-resistant bladder cancer cells with a pan-RAS inhibitor. |
| 雑誌名 | FEBS Open Bio. 13:1056-1066. 2023. |
| 発表者・ 共演者 |
Fukumoto W, Yoshino H, Horike SI, Kawakami I, Tamai M, Arima J, Kawahara I, Mitsuke A, Sakaguchi T, Inoguchi S, Meguro-Horike M, Tatarano S, Enokida H. |
| 題名 | Potential therapeutic target secretogranin II might cooperate with hypoxia-inducible factor 1α in sunitinib-resistant renal cell carcinoma. |
| 雑誌名 | Cancer Sci. 114:3946-3956. 2023. |
| 発表者・ 共演者 |
Kawahira H, Fujii K, Higashi Y, Yamada Y, Mitsuke A, Enokida H, Kanekura T. |
| 題名 | Double filtration plasmapheresis for bullous pemphigoid: Outcomes from the evaluation of eight patients. |
| 雑誌名 | Ther Apher Dial. 27:1048-1050.2023. |
| 発表者・ 共演者 |
Enoki Y, Naraki T, Saita K, Mori T, Mitsuke A, Sakaguchi T, Nishimura H, Tatarano S, Yamada Y, Enokida H. |
| 題名 | Inguinal Lymphadenopathy After Renal Transplantation Leading to the Diagnosis of Prostate Cancer: A Case Report. |
| 雑誌名 | Transplant Proc.55:1092-1094.2023. |
| 英文論文業績（2022年） | |
|---|---|
| 発表者・ 共演者 |
Tamai M, Tatarano S, Okamura S, Fukumoto W, Kawakami I, Osako Y, Sakaguchi T, Sugita S, Yonemori M, Yamada Y, Nakagawa M, Enokida H, Yoshino H. |
| 題名 | microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1. |
| 雑誌名 | Mol Oncol. 2022 Mar;16(6):1329-1346. |
| 発表者・ 共演者 |
Yoshino H, Tatarano S, Tamai M, Tsuruda M, Iizasa S, Arima J, Kawakami I, Fukumoto W, Kawahara I, Gang Li, Sakaguchi T, Inoguchi S, Yamada Y, Enokida H. |
| 題名 | Exosomal microRNA-1 and MYO15A as a target for therapy and diagnosis in renal cell carcinoma. |
| 雑誌名 | Biochem Biophys Res Commun . 2022 Nov 19;630:71-76. doi: 10.1016/j.bbrc.2022.09.056. |
| 発表者・ 共演者 |
Kawakami I, Yoshino H, Fukumoto W, Tamai M, Okamura S, Osako Y, Sakaguchi T, Inoguchi S, Matsushita R, Yamada Y, Tatarano S, Nakagawa M, Enokida H |
| 題名 | Targeting of the glutamine transporter SLC1A5 induces cellular senescence in clear cell renal cell carcinoma. |
| 雑誌名 | Biochem Biophys Res Commun . 2022 611:99-106. |
| 発表者・ 共演者 |
Tatarano S, Mitsuke A, Sakaguchi T, Matsushita R, Inoguchi S, Yoshino H, Nishimura H, Yamada Y, Enokida H. |
| 題名 | Laparoscopic Surgery for Pheochromocytoma in Hemodialysis Patients. |
| 雑誌名 | Int J Nephrol.2022:3060647,2022. |
| 英文論文業績（2021年） | |
|---|---|
| 発表者・ 共演者 |
Okamura S, Yoshino H, Kuroshima K, Tsuruda M, Osako Y, Sakaguchi T, Yonemori M, Yamada Y, Tatarano S, Nakagawa M, Enokida H. |
| 題名 | EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer. |
| 雑誌名 | BMC Cancer. 2021 Jan 11;21(1):48. doi: 10.1186/s12885-020-07717-0. |
| 発表者・ 共演者 |
Tatarano S, Enokida H, Yonemori M, Eura R, Yoshino H, Nishimura H, Yamada Y, Nakagawa M. |
| 題名 | Significance of perioperative screening of deep vein thrombosis and its indications for patients undergoing urological surgery. |
| 雑誌名 | Investig Clin Urol. 62:166-171,2021. |
| 和文論文業績（2021年） | |
|---|---|
| 発表者・ 共演者 |
松岡弘文, 坪内和女, 田中正利, 羽賀宣博, 山口孝則, 鯉川弥須宏, 宮里実, 斎藤誠一, 木原敏晴, 宮田康好, 望月保志, 酒井英樹, 榎田英樹, 速見浩士, 中川昌之, 森健一, 秦聡孝, 上村敏雄, 向井尚一郎, 賀本敏行, 猪口淳一, 江藤正俊, 藤本直浩, 末金茂高, 松尾光哲, 井川掌, 東武昇平, 野口満, 西一彦, 神波大己, 石井龍. |
| 題名 | 逆流性腎症の術後長期予後に関わる要因の検討 第18回九州泌尿器科連合地方会共同研究. |
| 雑誌名 | 西日本泌尿器科, 82;570-578,2021. |
| 国際学会発表（2021年） |
|---|
© 2021 Kagoshima University Department of Urology